First Databank, Inc. offers integrated drug databases/knowledge and drug decision support tools. It offers National Drug Data File (NDDF) Plus that provides information on over-the-counter (OTC) and alternative therapy agents; OrderView Med Orders Database for completing med orders; International Drug Data File–Canada with information on prescription and OTC medications; Multilex Drug Data File–Europe with clinical and commercial information; FDB OrderSpace, a Web-based solution that enables customization of medication ordering content in CPOE systems; and FDB AlertSpace, an alert management solution to address alert fatigue in computerized provider order entry systems. It offers content int...
701 Gateway Boulevard
South San Francisco, CA 94080
Founded in 1977
Seattle Children’s Integrates First Databank’s Meducation to Improve Patients’ Understanding of Their Medications
May 16 17
FDB (First Databank, Inc.) announced that Seattle Children’s Hospital has deployed the company’s Meducation® solution to ensure that pediatric patients and their family caregivers better understand how to take their medications. Meducation delivers medication instructions for individuals considered to be “high risk” due to low health literacy, poor vision or language barriers. Healthcare providers at Seattle Children’s can now access Meducation from within the workflow of their Cerner Millennium® electronic medical record system in both the inpatient and ambulatory environments.
FDB Launches Medical Device Knowledge Platform, FDB Prizm
Feb 13 17
FDB announced that it has launched a new medical device knowledge platform, FDB Prizm™. The platform – comprised of a structured and categorized medical device knowledge base made available via web service APIs – enables actionable insight on medical devices within healthcare information systems to help improve clinical, operational, and financial outcomes. FDB will debut FDB Prizm at the HIMSS 2017 Conference in booth #2531 and as part of the HIMSS 2017 Intelligent Health Pavilion™, booth #8361, in Orlando from February 19-23, 2017. The adoption of accountable care and value-based payment models challenges providers to cut costs while providing the best quality care and outcomes. Medical device information needs to be structured, complete, and readily available to enable providers to deliver value. Currently, medical device information within information systems is unstructured, incomplete, and in many cases unavailable, even though users of these systems need to rely on it to purchase, manage and bill for these products. The unique device identifier (UDI) is an important step that enables providers to track device safety and efficacy, but in reality, the marketplace requires a more comprehensive source for medical device information that goes beyond the UDI with high-quality, accurate, and structured knowledge. Medical device knowledge in FDB Prizm covers products that are implanted in patients such as hip replacements, pacemakers, and stents; surgical instruments and medical supplies such as catheters, forceps, gloves, gauze and syringes; hospital and durable medical equipment (DME) such as imaging systems, patient monitors, wheelchairs, and diabetic supplies. The content comes from a variety of sources including medical device manufacturers, industry data pools, providers, and government agencies and includes identifying information as well as clinical, operational, and financial attributes and codes. FDB’s experienced knowledge engineers take this vast amount of disparate data pertaining to more than six million medical devices and apply standardization and validation processes that have been proven for decades in medication knowledge management.
First Databank, Inc. and Translational Software, Inc. Announce Collaboration to Deliver Pharmacogenomic Drug Knowledge
Feb 6 17
First Databank, Inc. and Translational Software, Inc. (TSI) announced a collaboration to develop pharmacogenomics (PGx)-based drug knowledge within health information system workflows. The new drug knowledge will combine FDB’s MedKnowledge™ content and TSI’s proprietary PGx knowledge base data with relevant genomic-based laboratory findings to help clinicians make informed medication decisions for effective patient treatment. Integrated within the existing clinical workflow, the drug knowledge will provide pre-emptive testing prompts, genomic decision support, and advanced drug-drug-gene interaction alerting. Initial use cases will enable clinicians to consider the genomic profile of a patient when making prescribing decisions (such as recommendations for drug monitoring, dose adjustments or prescribe contraindicated); and to consider genomic-related risk information when two drugs are prescribed together. This functionality will help guide clinical decision making, minimize adverse reactions and enable physicians to prescribe the most effective medication in a manner that meets the unique needs of individual patients. The pharmacogenomics care guidance drug knowledge will be uniquely deployed through the FDB Cloud Connector™, a web services API platform, and will leverage interoperable drug vocabularies published by the ONC so that the services can be deployed regardless of the drug knowledge provider used in the clinician’s underlying electronic health record system. FDB will also draw on its deep clinical expertise and decades of experience in working with customers to optimize medication alerts to meet the unique needs of a particular practice setting.